Showing 1 - 7 results of 7 for search 'Nick Pavlakis', query time: 0.02s Refine Results
  1. 1
    Osteoclast inhibitors to prevent bone metastases in men with high-risk, non-metastatic prostate cancer: A systematic review and meta-analysis.

    Osteoclast inhibitors to prevent bone metastases in men with high-risk, non-metastatic prostate cancer: A systematic review and meta-analysis. by Aimee R Hayes, Daniel Brungs, Nick Pavlakis

    Published 2018-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET).

    Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET). by Matthew H Wong, David L Chan, Adrian Lee, Bob T Li, Sumit Lumba, Stephen J Clarke, Jaswinder Samra, Nick Pavlakis

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis.

    The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis. by David L Chan, Katrin M Sjoquist, David Goldstein, Timothy J Price, Andrew J Martin, Yung-Jue Bang, Yoon-Koo Kang, Nick Pavlakis

    Published 2017-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    CD11c+ and IRF8+ cell densities in rectal cancer biopsies predict outcomes of neoadjuvant chemoradiotherapy

    CD11c+ and IRF8+ cell densities in rectal cancer biopsies predict outcomes of neoadjuvant chemoradiotherapy by Benita C. Y. Tse, Sarah Bergamin, Pascal Steffen, George Hruby, Nick Pavlakis, Stephen J. Clarke, Justin Evans, Alexander Engel, Andrew Kneebone, Mark P. Molloy

    Published 2023-12-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    [18F]FMISO PET in metastatic neuroendocrine tumours: a pilot study

    [18F]FMISO PET in metastatic neuroendocrine tumours: a pilot study by David Chan, Alice Conner, Nick Pavlakis, Elizabeth Bailey, Alireza Aslani, Kathy Willowson, Connie Diakos, Elizabeth Bernard, Stephen Clarke, Alexander Engel, Paul Roach, Dale Bailey

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors

    Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metast... by Matthew Burge, David Goldstein, Andrew Haydon, Nick Pavlakis, Charlotte Lemech, Edward Hammond, Darryn Bampton, Keith Dredge, Michael P Brown, Andrew Clouston, Nigel J Waterhouse, Amanda C Stanley, Lucie Leveque-El Mouttie, Grace M Chojnowski

    Published 2023-01-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    A protocol for pre-treatment testing for antibodies to galactose-alpha-1,3-galactose to mitigate the risk of cetuximab hypersensitivity reactions – a retrospective cohort review

    A protocol for pre-treatment testing for antibodies to galactose-alpha-1,3-galactose to mitigate the risk of cetuximab hypersensitivity reactions – a retrospective cohort review by Nicholas Della Marta, Alexander Yuile, Claire Mok, Joe Wei, Meredith Oatley, Tracey Skinner, Samuel Miller, Amanda L. Hudson, Sheryl van Nunen, Stephen J. Clarke, Connie I. Diakos, Madhawa De Silva, David L. Chan, Gavin M. Marx, Nick Pavlakis

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: